T 0105/14 (Neisseria meningitidis bleb antigen/GLAXOSMITHKLEIN) of 12.04.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T010514.20190412
- Date of decision
- 12 April 2019
- Case number
- T 0105/14
- Petition for review of
- -
- Application number
- 06124081.8
- IPC class
- A61K 39/102C07K 14/195C12N 1/21A61K 39/118C12N 15/74C12N 15/67A61K 39/095A61K 39/116A61K 39/295A61K 39/104C12N 15/31A61K 39/09A61K 39/02
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Vaccine composition
- Applicant name
- GlaxoSmithKline Biologicals S.A.
- Opponent name
- The Kingdom of the Netherlands, represented by the Minister of Public Health, Welfare and Sports
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 104(1)European Patent Convention Art 113(1)European Patent Convention Art 114(2)European Patent Convention Art 83Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 15(3)Rules of procedure of the Boards of Appeal Art 16(1)
- Keywords
- Main request, auxiliary requests 1 to 9 and 11 to 15 - admission (no);
Auxiliary requests 10 and 16 to 19 - sufficiency of disclosure (no);
Apportionment of costs (no); - Catchword
- -
- Cited cases
- T 0280/15
Order
For these reasons it is decided that:
1. The appeal is dismissed.
2. The respondent's request for an apportionment of costs is rejected.